Cambridge, UK – 12th May 2014 – Cresset, innovative provider of computational chemistry software and services, announces its annual user meetings, ‘Field Based Chemistry North America’ and ‘Field Based Chemistry Europe’. Both meetings combine scientific presentations, product updates, and news on the latest Cresset research. There are also free expert training sessions for Cresset products at each meeting.
The North America meeting takes place on June 11th, 2014 in Cambridge, MA, USA. Presentations will be given by Novartis, Retrophin, Harvard Medical School, leading academics and Cresset scientists.
TheEuropean meeting takes place on June 19th - 20th, 2014 in Cambridge, UK. Presentations will be given by scientists from industry, academia and Cresset. This meeting features the panel debate, ‘Deploying modelling tools to medicinal chemists’.
“The Cresset ‘Field Based Chemistry’ meetings are excellent forums for the sharing of ideas, approaches and results, enabling our customers to benefit from combined experiences challenges and successes,” says Dr. Robert Scoffin, Cresset’s CEO. “In our industry, where confidentiality is so important, our customers value the chance to meet with peers and help one another on the path towards our common scientific goals.”
Cresset develops software for calculating and comparing the molecular field characteristics of chemical compounds. Cresset also offers consultancy services which enable companies to outsource computational chemistry work to achieve high value, on-demand expertise, particularly in the areas of library design, virtual screening, scaffold hopping, lead optimization and patent analysis.
Cresset’s field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. This field technology provides a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com
kdm communications limited
Suite 3, 12 Huntingdon Street
St Neots, PE19 1BG